previous  ...21222324252627282930  next  · entire list

China corners vitamin market
2007-06-03, Seattle Times (One of Seattle's two leading newspapers)
http://seattletimes.nwsource.com/html/nationworld/2003732744_vitamins03.html

If you pop a vitamin C tablet in your mouth, it's a good bet it came from China. Indeed, many of the world's vitamins are now made in China. In less than a decade, China has captured 90 percent of the U.S. market for vitamin C, driving almost everyone else out of business. Chinese pharmaceutical companies also have taken over much of the world market in the production of antibiotics, analgesics, enzymes and primary amino acids. According to an industry group, China makes 70 percent of the world's penicillin, 50 percent of its aspirin and 35 percent of its [Tylenol], as well as the bulk of vitamins A, B12, C and E. In the wake of a pet-food scandal, in which adulterated wheat gluten from China led to the deaths of thousands of pets in North America, and other instances of food and toothpaste tampering, China's vitamin producers are reaching out to reassure U.S. consumers that their vitamins are safe. Whether that's true isn't clear, however. Foreign food-safety experts say China's larger companies have reputations to protect. The question is how they maintain quality control. Since U.S. laws don't require food and drug sellers to label products with the country of origin of ingredients, it's impossible for consumers to know where food or supplements are coming from, not to mention what factory produced them.

Eli Lilly accused of shaping drug guidelines
2006-10-18, MSNBC/Associated Press
http://msnbc.msn.com/id/15320680/

Several government doctors say drug maker Eli Lilly & Co. subtly orchestrated medical guidelines for treatment of an often lethal blood infection, hoping to boost sales of a drug whose value is being debated. “This company is trying to insinuate its drug into many aspects of patient care that industry really shouldn’t be involved in,” said Dr. Naomi O’Grady, a critical care specialist at the National Institutes of Health. Three of her NIH colleagues claim in Thursday’s New England Journal of Medicine that Lilly worked through medical societies to influence standards for treating the blood infection, sepsis. Ultimately, Xigris was incorporated into the guidelines. Both the guidelines committee and a larger information campaign on sepsis were heavily funded by [Lilly]. Dr. Phil Dellinger, who helped lead the guidelines committee, said...“We’ve been catching grief because we’ve been taking a lot of Lilly money — and we’re appreciative of Lilly giving it.” The U.S. Food and Drug Administration approved Xigris in 2001, despite an evenly split vote by its advisory committee. The lead author of Thursday’s journal article, Dr. Peter Q. Eichacker, voted against approval. Some critics are unhappy that the drug, which works only for the sickest patients, was approved on the basis of a single experiment. Academic officials acknowledged in the published guidelines that Lilly gave more than 90 percent of $861,000 in grants for the campaign and medical recommendations. O’Grady, of NIH, said a panel of disease experts that she headed refused to endorse the sepsis guidelines largely because Lilly “convened the whole panel.”

Note: For lots more on how the powerful pharmaceutical industry endangers our lives, click here.

A Windfall From Shifts to Medicare
2006-07-18, New York Times
http://www.nytimes.com/2006/07/18/business/18place.html?ex=1310875200&en=64d0...

The pharmaceutical industry is beginning to reap a windfall from a surprisingly lucrative niche market: drugs for poor people. The windfall, which by some estimates could be $2 billion or more this year, is a result of the transfer of millions of low-income people into the new Medicare Part D drug program that went into effect in January. Under that program...the prices paid by insurers, and eventually the taxpayer, for the medications given to those transferred are likely to be higher than what was paid under the federal-state Medicaid programs. Analysts expect it to generate hundreds of millions of additional dollars this year for the drug companies. Drugs tend to be cheaper under the Medicaid programs because the states are the buyers and by law they receive the lowest available prices for drugs. But in creating the federal Part D program, Congress -- in what critics saw as a sop to the drug industry -- barred the government from having a negotiating role. The windfall for the drug makers was made possible by a provision of the 2003 Medicare law that exempts Part D drugs from "best price" rebates that the drug makers have been required to give to the state Medicaid programs. Those rebates are meant to make sure that state Medicaid agencies pay no more than the best prices drug companies offer to any big commercial insurer. Now, under Part D, all sorts of price deals will be negotiated by dozens of Medicare drug plans. The prices will be reported to Medicare, but under a provision of the law pushed by industry lobbyists, they will otherwise be kept secret.

Secretive society's big names include Kissinger, Rockefeller, a queen
2006-06-09, Toronto Star (one of Canada's leading newspapers)
http://www.thestar.com/NASApp/cs/ContentServer?pagename=thestar/Layout/Articl...

Among prominent attendees at this year's conference of the Bilderberg group, a secretive society that includes some of the world's most powerful people: Jacques Aigrain, CEO of Swiss Re. Ahmad Chalabi, former deputy prime minister of Iraq and long-time opponent of Saddam Hussein. George A. David, chairman of Coca-Cola. Paul Desmarais, CEO of Power Corporation. Richard Holbrooke, key American negotiator for 1995 Bosnian peace accords. Vernon Jordan, friend and onetime presidential aide to Bill Clinton. Henry Kissinger, foreign-policy guru and secretary of state under Richard Nixon. Ed Kronenburg, director of NATO's private office. Bernardino Leon Gross, Spain's foreign minister. Ronald S. Lloyd, chairman of Credit Suisse First Boston. Queen Beatrix of The Netherlands. Gordon Nixon, Royal Bank of Canada president, CEO. George Pataki, governor of New York state. Richard Perle, senior foreign policy adviser to U.S. President George W. Bush. David Rockefeller, retired banker, heir to oil fortune. Dennis Ross, former Clinton Mideast negotiator. Giulio Tremonti, VP of Italy's chamber of deputies. James Wolfensohn, U.S. Mideast envoy, former head of the World Bank. Robert Zoellick, deputy U.S. secretary of state.

Note: If the above link fails, click here. For those who know about the pre-war manipulations involving weapons of mass destruction in Iraq, the participation of Ahmed Chalabi speaks volumes. And for a revealing three-minute video clip on CNN about this highly secretive group, click here.

Oil refiners' golden age of profits
2006-04-27, San Francisco Chronicle (San Francisco's leading newspaper)
http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2006/04/27/MNG52IG4LV1.DTL

High crude oil prices aren't the only reason you're paying $3.15 for a gallon of regular. For America's giant gasoline refiners...this is a golden age. By California state estimates, refinery profit margins have more than doubled in 2006, though that figure doesn't take into account some key expenses. Meanwhile, oil prices have risen by 14 percent. Oil industry critics hunting for proof of price gouging point to refineries' expanding profit margins as evidence. Critics say the companies deliberately closed many U.S. refineries years ago as a way to drive up their margins. The country now has 144 refineries, down from 324 in 1981. "The refining business used to be pretty lousy, but they took very aggressive actions to correct that," said Tyson Slocum, director of the energy program at the Public Citizen watchdog group. "They're choosing not to build new refineries because it's not in their economic interest." Exact profit margins for the industry are difficult to track, because the companies involved don't reveal financial details. The California Energy Commission publishes a loose weekly estimate, measuring the difference between what the state's 21 refineries pay for crude oil and what they charge for their products. Since the start of the year, that figure has jumped 130 percent, from 30 cents for each gallon of finished gasoline to 69 cents last week. During the same time, the price refiners pay for crude oil has increased 14 percent.

The blog in the corporate machine
2006-02-09, The Economist
http://www.economist.com/business/displaystory.cfm?story_id=5501039

They have always had their critics, but corporations are having an especially hard time making friends of late. Scandals at Enron and WorldCom destroyed thousands of employees' livelihoods, raised hackles about bosses' pay and cast doubt on the reliability of companies' accounts. Big companies such as McDonald's and Wal-Mart have found themselves the targets of scathing films. Labour groups and environmental activists are finding new ways to co-ordinate their attacks on business. But those are just the enemies that companies can see. Even more troubling for many managers is dealing with their critics online -- because, in the ether, they have little idea who the attackers are. One of the main reasons that executives find bloggers so very challenging is because, unlike other 'stakeholders', they rarely belong to well-organised groups. That makes them harder to identify, appease and control. When a company is dealing directly with a labour union or an environmental outfit, its top brass often take the easy route, by co-opting the leaders or paying some sort of Danegeld. Until a couple of decades ago, that meant doling out generous union contracts and sticking shareholders, taxpayers or consumers with the bill. Increasingly, companies are learning that the best defence against these attacks is to take blogs seriously and fix rapidly whatever problems they turn up.

Despite Vow, Drug Makers Still Withhold Data
2005-05-31, New York Times
http://www.nytimes.com/2005/05/31/business/31trials.html?ex=1275192000&en=43d...

When the drug industry came under fire last summer for failing to disclose poor results from studies of antidepressants, major drug makers promised to provide more information about their research on new medicines. But nearly a year later, crucial facts about many clinical trials remain hidden. Eli Lilly and some other companies have posted hundreds of trial results on the Web and pledged to disclose all results for all drugs they sell. But other drug makers, including Merck and Pfizer, release less information and are reluctant to add more, citing competitive pressures. As a result, doctors and patients lack critical information about important drugs ... and the companies can hide negative trial results by refusing to publish studies, or by cherry-picking and highlighting the most favorable data. GlaxoSmithKline agreed to pay $2.5 million to settle a suit ... alleging that Glaxo had hidden results from trials showing that its antidepressant Paxil might increase suicidal thoughts in children and teenagers. Federal laws require the disclosure of all trials and trial results to the F.D.A. But companies are not required to disclose trial results to scientists or the public. Under pressure from the editors of medical journals, the major drug companies in January agreed to expand the number of trials registered on clinicaltrials.gov. Three companies have filed only vague descriptions of many studies, often failing even to name the drugs under investigation. For example, Merck describes one trial as a "one-year study of an investigational drug in obese patients."

Secretly, tiny nations hold much wealth
2005-04-25, Christian Science Monitor
http://www.csmonitor.com/2005/0425/p17s01-cogn.html

They're tax havens: 70 mostly tiny nations that offer no-tax or low-tax status to the wealthy so they can stash their money. Usually, the process is so secret that it draws little attention. But the sums - and lost tax revenues - are growing so large that the havens are getting new and unaccustomed scrutiny. There are about 3 million shell companies (set up largely to duck taxes) in offshore tax havens, Komisar reckons. These tiny tax havens hold 31 percent of total world assets and 26 percent of the stock of US multinationals.

Cancer Crusade
1931-03-23, Time Magazine
http://www.time.com/time/magazine/article/0,9171,741262,00.html

Drs. Coffey & Humber ... last year cautiously announced that they were alleviating hopeless cases of cancer by means of adrenal cortex extract derived from sheep. The Hearst press recognized the kernel of news in this announcement and puffed it so that thousands of cancer victims abandoned the orthodox treatment of surgery, X-rays and radium, rushed for the sure-cure. The two doctors were amazed, but nonetheless swam with the tide of publicity and patients. They opened auxiliary clinics at Los Angeles and Long Beach. They went before a Senate committee to argue for Government aid for cancer research. They gained a patent for their extract. Mrs. Grace Hammond Conners ... gave Drs. Coffey & Humber her $1,000,000 estate, "The Monastery," at Huntington, L. I. Although Dr. Hartwell & friends who last week opposed opening "The Monastery" as a clinic "do not for a minute question the sincerity of Drs. Coffey and Humber in believing they have something of value," the critics "do question the way they have handled their work." The New York men are certain that their San Francisco colleagues have had no training to qualify for research in "the most complex field that exists" in medicine. They do not believe that adrenal cortex extract will cure cancer or that it has value in cancer treatment. They fear that the Californians will experiment on New York humans, hence want them (or at least their methods; excluded, to remain in California where patients are "abundantly available." This was obviously a campaign to ostracize Drs. Coffey & Humber from Manhattan's vicinity. It was conducted ... "by persons who had their own methods, hospitals and funds."

Note: The doctors eventually not only were denied permission to open a cancer clinic for their promising work, they were stripped of the $1 million dollar estate donated to them (worth about $15 million in current U.S. dollars). For the full, fascinating story, click here.

End Is Seen to Free Checking
2010-06-16, Wall Street Journal
http://online.wsj.com/article/SB10001424052748703513604575311093932315142.html

Bank of America Corp. and other banks are preparing new fees on basic banking services as they try to replace revenue lost to regulatory rules, in a push that is expected to spell an end to free checking accounts for many Americans. Free checking accounts, which have been widely available for more than a decade, have been a boon to middle-class consumers and attracted low-income customers to the banking system for the first time. Customers will likely be required to pay new monthly maintenance fees on the most basic accounts that don't generate a lot of activity. To avoid a fee, customers will have to maintain certain account balances or frequently use other banking services, such as credit and debit cards, automated teller machines and online accounts. Some consumer advocates warn the new fees will whack consumers who now manage their bank accounts to avoid such charges. The transformation of checking accounts comes at a time when banks are bouncing back from the steepest financial losses in a generation and are facing new regulations. To accelerate that recovery and recoup losses from new banking rules, financial institutions are increasingly leaning on customers who don't now generate enough revenue for the bank.

Note: Why hasn't the federal government protected consumers from this sort of response by the banking industry to new regulations imposed after the massive taxpayer bailout of these failing corporations?

Federal No-Bid Contracts On Rise
2007-08-22, Washington Post
http://www.washingtonpost.com/wp-dyn/content/article/2007/08/22/AR20070822000...

Last year, officials at the Department of Homeland Security's counter-narcotics office took a shortcut that has become common at federal agencies: They hired help through a no-bid contract. And the firm they hired showed them how to do it. A contract worth up to $579,000 was awarded to the consultant's firm in September. Though small by government standards, the counter-narcotics contract illustrates the government's steady move away from relying on competition to secure the best deals for products and services. A recent congressional report estimated that federal spending on contracts awarded without "full and open" competition has tripled, to $207 billion, since 2000, with a $60 billion increase last year alone. The category includes deals in which officials take advantage of provisions allowing them to sidestep competition for speed and convenience and cases in which the government sharply limits the number of bidders or expands work under open-ended contracts. Government auditors say the result is often higher prices for taxpayers and an undue reliance on a limited number of contractors. "The rapid growth in no-bid and limited-competition contracts has made full and open competition the exception, not the rule," according to the report, by the House Oversight and Government Reform Committee. Keith Ashdown, chief investigator at Taxpayers for Common Sense, a nonpartisan watchdog group, said that in many cases, officials are simply choosing favored contractors as part of a "club mentality." "Contracting officials are throwing out decades of work to develop fair and sensible rules to promote competition," Ashdown said. "Government officials are skirting the rules in favor of expediency or their favored contractors."

Scientists issue warning on chemical
2007-08-03, Los Angeles Times
http://www.latimes.com/news/nationworld/nation/la-na-plastic3aug03,0,1828523....

In an unusual effort targeting a single chemical, several dozen scientists on Thursday issued a strongly worded consensus statement warning that an estrogen-like compound in plastic is likely causing an array of serious reproductive disorders in people. The compound, bisphenol A or BPA, is one of the highest-volume chemicals in the world and has found its way into the bodies of most human beings. Used to make hard plastic, BPA can seep from beverage containers and other materials. It is used in all polycarbonate plastic baby bottles as well as ... large water cooler containers, sports bottles and microwave oven dishes, along with canned food liners and some dental sealants for children. The scientists — including four from federal health agencies — reviewed about 700 studies before concluding that people are exposed to levels of the chemical exceeding those that harm lab animals. Infants and fetuses are most vulnerable, they said. The statement, published online by the journal Reproductive Toxicology, was accompanied by a new study from researchers from the National Institutes of Health that found uterine damage in newborn animals exposed to BPA. That damage is a possible predictor of reproductive diseases in women, including fibroids, endometriosis, cystic ovaries and cancers. It is the first time BPA has been linked to disorders of the female reproductive tract, although earlier studies have found early-stage prostate and breast cancer and decreased sperm counts in animals exposed to low doses. The scientists' statement and the new study — accompanied by five scientific reviews summarizing the 700 studies — intensify a contentious debate over whether the plastic compound poses a public threat. So far no government agency here or abroad has restricted its use.

Attack of the mutant rice
2007-07-02, Fortune magazine
http://money.cnn.com/magazines/fortune/fortune_archive/2007/07/09/100122123/i...

In the spring of 2001, a ... rice farmer named Jacko Garrett watched a fleet of 18-wheelers haul away truckloads of rice that he had grown with great care. "It just bothers me so bad," Garrett said. "I'm sitting here trying to find food to feed people, and I've got to bury five million pounds of rice." Garrett's rice was genetically modified, part of an experiment that was brought to an abrupt halt by its sponsor, a ... biotechnology company called Aventis Crop Science. The company had contracted with a handful of farmers to grow the rice, which was known as Liberty Link because its genes had been altered to resist a weed killer called Liberty, also made by Aventis. In January 2006, small amounts of genetically engineered rice turned up in a shipment that was tested ... by a French customer of Riceland Foods. Because no transgenic rice is grown commercially in the U.S., the people at Riceland were stunned. Then came another shock. Testing revealed that the genetically modified rice contained a strain of Liberty Link that had not been approved for human consumption. What's more, trace amounts of the Liberty Link had mysteriously made their way into the commercial rice supply in all five of the Southern states where long-grain rice is grown. The tainted rice was everywhere. If in the past year or so you or your family ate Uncle Ben's, Rice Krispies, or Gerber's, or drank a Budweiser ... you probably ingested a little bit of Liberty Link, with the unapproved gene. Last November, over the howls of anti-GMO activists, the USDA retroactively approved the Liberty Link rice, known as LL601. The department said the genes that it approved are similar to those inserted for years into canola and corn, with no apparent ill effects.

Note: To read a ten-page summary of Seeds of Deception, a ground-breaking exposé of the dangers of the genetic engineering of foods, click here.

Senators who weakened drug bill got millions from industry
2007-05-16, USA Today
http://www.usatoday.com/news/washington/2007-05-10-senators-drug-bill_N.htm

Senators who raised millions of dollars in campaign donations from pharmaceutical interests secured industry-friendly changes to a landmark drug-safety bill. The bill, which passed 93-1, grants the Food and Drug Administration broad new authority to monitor the safety of drugs after they are approved. It addressed some shortcomings that allowed the painkiller Vioxx to stay on the market for years after initial signs that it could cause heart attacks. However, the powers granted to the FDA in the bill's original version were pared back during private meetings. And efforts to curb conflicts of interest among FDA advisers and allow consumers to buy cheaper drugs from other countries were defeated in close votes. A measure that blocked an effort to allow drug importation passed, 49-40. The 49 senators who voted against drug importation received about $5 million from industry executives and political action committees since 2001 — nearly three quarters of the industry donations to current members of the Senate. Sen. Bernie Sanders, I-Vt. [was] the lone vote against the bill. "You have a culture in which big money has significant influence. Big money gains you access, access gives you the time to influence people." The pharmaceutical companies spend more money on lobbying than any other single industry — $855 million from 1998 to 2006. The biggest drug trade group, Pharmaceutical Research and Manufacturers of America, praised the bill after it passed. The group's spokesman, Ken Johnson, said its critics "never point out that a great deal of this money is spent trying to defeat bills … that are designed to cripple this industry."

Note: For lots more reliable, verifiable information on drug company manipulations, click here.

AT+T revises privacy policy, says owns customer data
2006-06-22, ABC News/Reuters
http://abcnews.go.com/US/wireStory?id=2105967

AT&T Inc. said on Wednesday it was revising its privacy policy, explaining to customers that it owns their phone records and can hand them over to law enforcers if necessary. The changes...come at a time when AT&T and other phone companies face lawsuits claiming they aided a U.S. government domestic spying program by giving the National Security Agency call records of millions of customers without their permission. The new policy, unlike the old one, spells out the fact that AT&T...customer information constitutes "business records that are owned by AT&T. As such, AT&T may disclose such records to protect its legitimate business interests, safeguard others, or respond to legal process." The earlier policy had simply said that...the company could share customer information to "respond to subpoenas, court orders or other legal process, to the extent required and/or permitted by law." Under the new policy...the company also said that it would track viewing information for customers of a television service it is developing in order to help it make recommendations to customers based on their viewing habits. It also said that before customers use its services they must agree to the policy, an element that was not in its previous guidelines.

Drug firms accused of turning healthy people into patients
2006-04-11, The Guardian (One of the U.K.'s leading newspapers)
http://www.guardian.co.uk/science/story/0,,1751362,00.html

According to reports published today...healthy people are being turned into patients by drug firms which publicise mental and sexual problems and promote little-known conditions only then to reveal the medicines they say will treat them.The studies, published in a respected medical journal, accuse the pharmaceutical industry of "disease mongering" - a practice in which the market for a drug is inflated by convincing people they are sick and in need of medical treatment. The "corporate-sponsored creation of disease" wastes resources and may even harm people because of the medication they turn to, the researchers add. In 11 papers in the journal Public Library of Science Medicine, experts from Britain, the US and elsewhere argue that new diseases are being defined by specialists who are often funded by the drug industry.According to the researchers, the campaigns boost drug sales by medicalising aspects of normal life.

Note: For more on how the pharmaceutical companies can negatively impact your health and your wallet:
http://www.WantToKnow.info/healthcoverup

Congress eyes voting machines in disputed race
2007-06-15, Miami Herald (Miami's leading newspaper)
http://www.miamiherald.com/569/story/140319.html

A congressional task force called Thursday for a speedy resolution to a southwest Florida election dispute that questions the accuracy of ATM-style voting machines. Democrat Christine Jennings claims that touch-screen voting machines in Sarasota County failed to register up to 18,000 votes. Republican Vern Buchanan was declared the winner by 369 votes after two recounts and a state audit found no problems. GAO investigators will gather information on Sarasota County's voting systems, analyze the 18,000 so-called ''undervotes,'' review tests and audits done after the election and determine if more tests are needed. Jennings said Thursday the she was pleased even though the approach brings her no closer to gaining access to hardware and software that the machines' maker, Omaha, Neb.-based Election Systems & Software Inc., says is a trade secret.

Note: The software in electronic voting machines is considered proprietary information, kept secret from Congress, the courts and even the President. Yet any computer programmer will tell you that this software can be manipulated. To join in demanding transparency in our elections process, contact your political representatives by clicking here. For more reliable information on this issue vital to democracy, click here.

The Dubai Deal You Don't Know About
2006-03-09, Time Magazine
http://www.time.com/time/business/article/0,8599,1171773,00.html

Dubai Ports World, the firm at the center of the controversy, announced today that it would give up its bid to manage U.S. ports, agreeing to transfer the contracts to a “U.S. entity." Yet while one Dubai company may be giving up on U.S. ports, another one shows no signs of...giving up a contract with the Navy to provide shore services for vessels in the Middle East. The firm, Inchcape Shipping Services (ISS)...was sold to a Dubai government investment vehicle for $285 million. Why is a Dubai shipping services company doing business with the Pentagon when handing over U.S. port operations to the emirate would supposedly compromise national security? ISS “will be responsible for providing all the logistics requirements of U.S. Navy and Coast Guard ships in ports throughout the [Middle East] region.” The release also notes that ISS may be asked to provide services for U.S. military training exercises and “contingency operations inland.” ISS’s partner for those services? None other than KBR, the division of Halliburton -- Vice President Dick Cheney’s old firm -- that has won billions of dollars in contracts for the Iraq war and reconstruction. Ironically, Halliburton's name has come up as a possible candidate to be the "U.S. entity" to take over the U.S. ports management from Dubai Ports World.

Midwest Oil fined for selling gas too cheaply
2006-02-24, Star Tribune (Leading newspaper of Minneapolis-St. Paul)
http://www.startribune.com/535/story/267143.html

The Minnesota Commerce Department on Thursday announced plans to fine a gas station chain $140,000 for repeatedly selling gas below the state's legal minimum price. The fine against Midwest Oil of Minnesota is twice as large as any imposed on a company since 2001, when the state established a formula based on wholesale prices, fees and taxes to determine a daily floor for gas prices. The price law was intended to prevent large oil companies from driving smaller competitors out of business, but some critics argue it fails to protect consumers. According to the Commerce Department, the Midwest-owned stations in Anoka, Oakdale and Albert Lea sold gas below the minimum price on 293 days in 2005. Kevin Murphy, deputy commissioner of the department, called the violations "willful, continuing, and egregious and warrant a substantial penalty."

Facing foreclosure? Don't leave. Squat
2009-02-04, San Francisco Chronicle (San Francisco's leading newspaper)
http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2009/02/04/EDK215MNA0.DTL

Marcy Kaptur of Ohio is the longest-serving Democratic congresswoman in U.S. history. Her district, stretching along the shore of Lake Erie from west of Cleveland to Toledo, faces an epidemic of home foreclosures and 11.5 percent unemployment. Now, she is recommending a radical foreclosure solution from the floor of the U.S. Congress: "So I say to the American people, you be squatters in your own homes. Don't you leave." She criticizes the bailout's failure to protect homeowners facing foreclosure. These mortgages were made, then bundled into securities and sold and resold repeatedly, by the very Wall Street banks that are now benefiting from [a government bailout]. The banks foreclosing on families very often can't locate the actual loan note that binds the homeowner to the bad loan. "Produce the note," Kaptur recommends [to] those facing foreclosure demands of the banks. "[P]ossession is nine-tenths of the law," Rep. Kaptur [said]. "Therefore, stay in your property. Get proper legal representation ... [if] Wall Street cannot produce the deed nor the mortgage audit trail ... you should stay in your home. It is your castle. It's more than a piece of property. ... If you look at the bad paper, if you look at where there's trouble, 95 to 98 percent of the paper really has moved to five institutions: JPMorgan Chase, Bank of America, Wachovia, Citigroup and HSBC. They have this country held by the neck."

Note: Why is it that with the trillions of dollars given by the U.S. government to prop up banks who used shady loan practices, so few homeowners facing foreclosure have received any assistance? For many revealing reports on the realities of the Wall Street bailout, click here.

previous

...21222324252627282930

next

· entire list